Share Structure - Updated June 1, 2024 Transfer

Share Structure - Updated June 1, 2024

Transfer Agent Verified

No change - no dilution since the 100M reduction on April 23 - 39 days

Authorized Shares:22,000,000,000

Outstanding Shares: 12,760,268,251

Restricted: 940,101,702

Unrestricted: 11,820,166,549

Note 1: It is only the Unrestricted Outstanding Shares count that is relevant to immediate trading.

Note 2: The company confirmed that there will be no further conversions for 4 months [source: 'X' update April 8, 2024]

Note 3: The company subsequently confirmed that a formal agreement had been signed with the last remaining convertible note holder stating that there would be no further conversions until next year [source: 'X' update May 28, 2024]

Note 4: More share cancellations planned [source: 'X' update April 29, 2024]

Note 5: Intention for share buyback ahead confirmed [latest source: 2024 Shareholder Update Letter].

Note 6: No reverse split confirmed again (for the 8th time) [latest source: 'X' update May 31, 2024].

Note 7: The company has now received approval to use the non-dilutive EB-5 Immigrant Investor Program to raise $20M for its current projects [latest source: 2024 Shareholder Update Letter].

Note 8: The company also has a comprehensive plan to raise $100M for future acquisitions and investments.

Note 9: The company also has $400K in cash coming in for 2 x ABA Canada license fees [source: PR dated March 11, 2024].

Note 10: The company also has secondary funding of $50M coming in to support its African, Canadian and US 6-picture film slate [source: Update on March 14, 2024].

Note 11: Market capitalization is projected to surpass $200 Million - fulfilling a criteria for uplisting to the NASDAQ [latest source: 2024 Shareholder Update Letter].

Note 12: Even before the future planned reductions and later share buyback, a market cap of $200M (higher expected) divided by the Outstanding Shares would equate to a pps of .0156.

"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.